Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial
RDT-ACT
Effects of Restricting the Use of AS-AQ Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial
1 other identifier
interventional
3,063
1 country
1
Brief Summary
Effective use of Rapid Diagnostic Test (RDT) and artemisinin-based combination therapy (ACT) depends on the accuracy and safety of RDT based treatment practices and on factors related to the health delivery system. We propose to study the accuracy and safety of RDT based diagnosis and treatment of febrile illness, health system determinants of effective use of RDTs and the public health outcomes of RDT based ACT for malaria.A cluster randomised trial of RDT based versus clinical judgment based treatment of febrile illness on the incidence of malaria in \<48 month old children will be conducted. Health Centres will be randomly allocated to RDT based treatment or clinical judgment based treatment arm and children under 2years of age from the catchment area of each health centre will be followed for 2 years. The cost effectiveness of RDT based approach will be compare with the clinical judgement based treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Mar 2009
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2009
CompletedFirst Posted
Study publicly available on registry
January 30, 2009
CompletedStudy Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedDecember 21, 2012
December 1, 2012
3.4 years
January 29, 2009
December 20, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of malaria (fever + any level of parasite density) in < 48 month-old children (Stage 2, Component A)
Three years
Secondary Outcomes (1)
Incidence of severe anaemia (Hb <8 g/dl) in < 48 month old children
Three years
Study Arms (2)
RDT+ACT group
EXPERIMENTALRDT+ACT group (ACT offered to RDT positive cases only)
Clinical judgement+ACT group
ACTIVE COMPARATORClinical judgement+ACT group (ACT offered to all suspected cases of malaria by clinical judgement)
Interventions
Study children attending RDT+ACT HCs with a febrile illness will be tested with an RDT to confirm malaria and treated with ACT only if they have a positive test for malaria parasite. However if there are signs suggestive of other co-morbidities they will be treated with appropriate medicines in addition to AS+AQ.
Study children attending RDT+ACT HCs with a febrile illness will be tested with an RDT to confirm malaria and treated with ACT only if they have a positive test for malaria parasite. However if there are signs suggestive of other co-morbidities they will be treated with appropriate medicines in addition to AS+AQ.
Eligibility Criteria
You may qualify if:
- All children aged less than 48mths reporting to health center with suspected malaria
You may not qualify if:
- Children having chronic illnesses such as severe malnutrition and heart disease will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kintampo Health Research Center
Kintampo, BAR, 200, Ghana
Related Publications (3)
Tawiah T, Hansen KS, Baiden F, Bruce J, Tivura M, Delimini R, Amengo-Etego S, Chandramohan D, Owusu-Agyei S, Webster J. Cost-Effectiveness Analysis of Test-Based versus Presumptive Treatment of Uncomplicated Malaria in Children under Five Years in an Area of High Transmission in Central Ghana. PLoS One. 2016 Oct 3;11(10):e0164055. doi: 10.1371/journal.pone.0164055. eCollection 2016.
PMID: 27695130DERIVEDBaiden F, Bruce J, Webster J, Tivura M, Delmini R, Amengo-Etego S, Owusu-Agyei S, Chandramohan D. Effect of Test-Based versus Presumptive Treatment of Malaria in Under-Five Children in Rural Ghana--A Cluster-Randomised Trial. PLoS One. 2016 Apr 7;11(4):e0152960. doi: 10.1371/journal.pone.0152960. eCollection 2016.
PMID: 27055275DERIVEDBaiden F, Webster J, Tivura M, Delimini R, Berko Y, Amenga-Etego S, Agyeman-Budu A, Karikari AB, Bruce J, Owusu-Agyei S, Chandramohan D. Accuracy of rapid tests for malaria and treatment outcomes for malaria and non-malaria cases among under-five children in rural Ghana. PLoS One. 2012;7(4):e34073. doi: 10.1371/journal.pone.0034073. Epub 2012 Apr 13.
PMID: 22514617DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frank E Baiden
Kintampo Health Research Center
- PRINCIPAL INVESTIGATOR
Jayne Webster
London School of Hygiene and Tropical Medicine
- PRINCIPAL INVESTIGATOR
Christopher Whitty
London School of Hygiene and Tropical Medicine
- PRINCIPAL INVESTIGATOR
Seth Owusu-Agyei
Kintampo Health Research Center
- PRINCIPAL INVESTIGATOR
Daniel Chandramohan
London School of Hygiene and Tropical Medicine
- PRINCIPAL INVESTIGATOR
Jane Bruce
London School of Hygiene and Tropical Medicine
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 29, 2009
First Posted
January 30, 2009
Study Start
March 1, 2009
Primary Completion
August 1, 2012
Study Completion
December 1, 2012
Last Updated
December 21, 2012
Record last verified: 2012-12